Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Quest Diagnostics Launches Simplexaâ„¢ C. Difficile Universal Direct Test in Europe

May 5, 2011 By Bio-Medicine.Org

MADISON, N.J. and CYPRESS, Calif., May 5, 2011 /PRNewswire/ —
Quest Diagnostics Incorporated (NYSE:
DGX
), the world’s leading provider of diagnostic testing,
information and services, today announced the availability in
Europe of the Simplexa C. difficile Universal Direct test on
the 3M™ Integrated Cycler. The new CE marked in vitro
diagnostic
(IVD) Simplexa test enables fast, high volume lab
testing, eliminating the traditional extraction step and allowing
for processing of up to 94 patient specimens in about an hour.

Focus Diagnostics, a business of Quest Diagnostics and developer
of the Simplexa product line, will unveil the new test as well as
the Simplexa Epstein Barr (EBV) and BK Virus tests, which were CE
marked last month, during the European Congress of Clinical
Microbiology and Infectious Disease Tradeshow, which begins on May
7 in Milan (Exhibit number: 241). A CE mark is a regulatory
requirement to sell products in about 35 countries in Europe.

Simplexa tests, running on the 3M™ Integrated Cycler,
employ real-time polymerase chain reaction (RT-PCR) to
qualitatively and quantitatively detect viruses, bacteria and other
agents. The Simplexa C. difficile Universal Direct test is
performed on liquid or unformed human stool samples and detects
toxin producing strains of Clostridium difficile, including
NAP1/B1/027.

“Clostridium difficile is a common cause of
antibiotic-associated diarrhea and an extremely important and
serious hospital-acquired infection,” said Jay M. Lieberman, M.D.,
medical director for Quest Diagnostics and Focus Diagnostics.
 “C. difficile infections (CDI) range in severity from
mild diarrhea to life-threatening pseudomembranous colitis, and
result in significant suffering and deaths. Timely diagnosis is
essential for clinicians when treating patients presenting with
possibl

‘/>”/>

SOURCE

Related Articles Read More >

UMN artificial blood vessel clinical trial
Minnesota researchers awarded $3.7M grant for artificial, bioengineered blood vessel clinical trial
CeQur Simplicity
CeQur is launching a discreet, convenient ‘wearable insulin pen’
Blackrock's Utah array is a miniature array of electrodes for sensing brain signals
Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
Engineer inspecting artificial hip joint parts in quality control department in orthopaedic factory
Deburring and finishing for beautiful, functional medical devices

DeviceTalks Weekly.

August 5, 2022
DTW Medtronic's Greg Smith lays out supply chain strategies
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech